The long-term health effects of human exposure to polybrominated biphe
nyls are not known. In this nested case-control study, we evaluated th
e association between site-specific cancer risk and serum polybrominat
ed biphenyl levels among a Michigan cohort accidentally exposed to pol
ybrominated biphenyls in 1973. The Michigan Department of Public Healt
h has followed 3,899 people through 1993, among whom 195 primary cance
rs were identified in 187 persons. Controls were 696 randomly selected
cancer-free individuals who were frequency matched to cases by sex an
d age (in 5-year strata). Baseline serum polybrominated biphenyl level
s were measured using standard methods. We found an increasing dose-re
sponse relation for digestive system cancer risk with higher serum pol
ybrominated biphenyl category [4-20 parts per billion (ppb), 21-50 ppb
, and >50 ppb] after adjustment for age, family cancer history, cigare
tte smoking, alcohol drinking, and baseline serum polychlorinated biph
enyl level. Adjusted odds ratios (ORs) for each category were 8.23 [95
% confidence interval (CI) = 1.27-53.3], 12.3 (95% CI = 0.80-191), and
22.9 (95% CI = 1.34-392), respectively. Univariate analysis for polyb
rominated biphenyl level and lymphoma risk also showed a dose-response
relation, with corresponding ORs of 3.24 (95% CI = 0.24-95.9), 20.5 (
95% CI = 1.51-608), and 32.6 (95% CI = 3.33-861).